Related Experiment Videos
[Echocardiographic changes in 91 patients with acromegaly]
Zhonghua Yi Xue Za Zhi
|September 1, 1991
Summary
Acromegalic cardiomyopathy affects 85.5% of patients with active acromegaly, characterized by left ventricular hypertrophy or dilation. This condition is linked to elevated growth hormone levels.
Area of Science:
- Cardiology
- Endocrinology
- Medical Imaging
Background:
- Acromegaly, a condition caused by excess growth hormone (GH), can lead to cardiovascular complications.
- Cardiac involvement in acromegaly, known as acromegalic cardiomyopathy, requires thorough investigation.
Purpose of the Study:
- To assess the prevalence and characteristics of acromegalic cardiomyopathy in patients with acromegaly.
- To investigate the relationship between active acromegaly and cardiac structural changes.
Main Methods:
- Echocardiography was utilized to evaluate cardiac structure and function in 91 acromegaly patients.
- Measurements included left ventricular internal diameter, wall thickness, and left ventricular mass.
- Analysis focused on 76 patients with active acromegaly (GH > 5 ng/ml).
Main Results:
- The incidence of acromegalic cardiomyopathy was 85.5% in active acromegaly patients.
- Active acromegaly patients exhibited significantly increased left ventricular mass (339.1 ± 85.6 g; 188.8 ± 46.7 g/m²).
- Left ventricular hypertrophy and/or dilation were common, with predominantly symmetric patterns; right ventricular hypertrophy was rare.
Conclusions:
- Acromegalic cardiomyopathy is highly prevalent in active acromegaly.
- Elevated growth hormone levels are strongly associated with cardiac remodeling in acromegaly.
- Echocardiography is crucial for diagnosing and monitoring cardiac changes in acromegaly.